Triflunordazepam: Difference between revisions

Browse history interactively ← Previous edit Next edit →Content deleted Content addedVisual WikitextInline

Revision as of 20:38, 20 September 2011 editCheMoBot (talk \| contribs)Bots141,565 edits Updating {{drugbox}} (no changed fields - added verified revid - updated 'ChemSpiderID_Ref', 'UNII_Ref', 'ChEMBL_Ref', 'ChEBI_Ref', 'KEGG_Ref', 'StdInChI_Ref', 'StdInChIKey_Ref', 'ChEBI_Ref') per Chem/Drugbox validation (report [[Wik← Previous edit		Revision as of 16:20, 20 November 2011 edit undo86.30.243.179 (talk) added original patentNext edit →
Line 27:		Line 27:
	}}		}}

	'''Ro5-2904''' ('''Triflunordazepam''') is a drug which is a ] derivative with high ] affinity, and has ] effects.<ref>''Archives Internationales de Pharmacodynamie et de Therapie''. (1965). Vol 154, p 131.</ref><ref name="pmid8978853">{{cite journal \|author=So SS, Karplus M \|title=Genetic neural networks for quantitative structure-activity relationships: improvements and application of benzodiazepine affinity for benzodiazepine/GABAA receptors \|journal=Journal of Medicinal Chemistry \|volume=39 \|issue=26 \|pages=5246–56 \|year=1996 \|month=December \|pmid=8978853 \|doi=10.1021/jm960536o \|url=}}</ref>		'''Ro5-2904'''<ref>DE Patent 1136709</ref> ('''Triflunordazepam''') is a drug which is a ] derivative with high ] affinity, and has ] effects.<ref>''Archives Internationales de Pharmacodynamie et de Therapie''. (1965). Vol 154, p 131.</ref><ref name="pmid8978853">{{cite journal \|author=So SS, Karplus M \|title=Genetic neural networks for quantitative structure-activity relationships: improvements and application of benzodiazepine affinity for benzodiazepine/GABAA receptors \|journal=Journal of Medicinal Chemistry \|volume=39 \|issue=26 \|pages=5246–56 \|year=1996 \|month=December \|pmid=8978853 \|doi=10.1021/jm960536o \|url=}}</ref>

	==See also==		==See also==

Revision as of 16:20, 20 November 2011

Pharmaceutical compound

Triflunordazepam
Clinical data

ATC code	none
Identifiers
IUPAC name 5-phenyl-7-(trifluoromethyl)-1,3-dihydro-1,4-benzodiazepin-2-one
CAS Number	2285-16-7
PubChem CID	16795
CompTox Dashboard (EPA)	DTXSID70177394
Chemical and physical data
Formula	C₁₆H₁₁F₃N₂O
Molar mass	304.267 g·mol
3D model (JSmol)	Interactive image
SMILES C1C(=O)NC2=C(C=C(C=C2)C(F)(F)F)C(=N1)C3=CC=CC=C3
(verify)

Ro5-2904 (Triflunordazepam) is a drug which is a benzodiazepine derivative with high GABA_A receptor affinity, and has anticonvulsant effects.

References

DE Patent 1136709
Archives Internationales de Pharmacodynamie et de Therapie. (1965). Vol 154, p 131.
So SS, Karplus M (1996). "Genetic neural networks for quantitative structure-activity relationships: improvements and application of benzodiazepine affinity for benzodiazepine/GABAA receptors". Journal of Medicinal Chemistry. 39 (26): 5246–56. doi:10.1021/jm960536o. PMID 8978853. {{cite journal}}: Unknown parameter |month= ignored (help)

v t e Benzodiazepines
1,4-Benzodiazepines	2-Oxoquazepam 3-Hydroxyphenazepam Bromazepam BMS-906024* Camazepam Carburazepam Chlordiazepoxide Cinazepam Cinolazepam Clonazepam Cloniprazepam Clorazepate Cyprazepam Delorazepam Demoxepam Desmethylflunitrazepam Devazepide* Diazepam Diclazepam Difludiazepam Doxefazepam Elfazepam Ethyl carfluzepate Ethyl dirazepate Ethyl loflazepate Flubromazepam Fletazepam Fludiazepam Flunitrazepam Flurazepam Flutemazepam Flutoprazepam Fosazepam Gidazepam Halazepam Iclazepam Irazepine* Kenazepine Ketazolam Lorazepam Lormetazepam Lufuradom* Meclonazepam Medazepam Menitrazepam Metaclazepam Motrazepam N-Desalkylflurazepam Nifoxipam Nimetazepam Nitemazepam Nitrazepam Nitrazepate Nordazepam Nortetrazepam Oxazepam Phenazepam Pinazepam Pivoxazepam Prazepam Proflazepam Quazepam QH-II-66 Reclazepam RO4491533* Ro05-4082 Ro5-4864* Ro07-5220 Ro07-9749 Ro20-8065 Ro20-8552 SH-I-048A Sulazepam Temazepam Tetrazepam Tifluadom* Timelotem* Tolufazepam Triflunordazepam Tuclazepam Uldazepam
1,5-Benzodiazepines	Arfendazam Clobazam CP-1414S Lofendazam Triflubazam
2,3-Benzodiazepines*	Girisopam GYKI-52466 GYKI-52895 Nerisopam Talampanel Tofisopam
Triazolobenzodiazepines	Adinazolam Alprazolam Balovaptan* Bromazolam Clonazolam Estazolam Fluadinazolam Flualprazolam Flubromazolam Flunitrazolam Nitrazolam Phenazolam Pyrazolam Rilmazolam (active metabolite of Rilmazafone) Triazolam
Imidazobenzodiazepines	Bretazenil Climazolam EVT-201 FG-8205 Flumazenil GL-II-73 Imidazenil I-Iomazenil L-655,708 Loprazolam Midazolam PWZ-029 Remimazolam Ro15-4513 Ro48-6791 Ro48-8684 Ro4938581 Sarmazenil SH-053-R-CH3-2′F
Oxazolobenzodiazepines	Cloxazolam Flutazolam Haloxazolam Mexazolam Oxazolam
Thienodiazepines	Bentazepam Clotiazepam Ro09-9212
Thienotriazolodiazepines	α-Hydroxyetizolam Apafant* Brotizolam Ciclotizolam Clotizolam Deschloroclotizolam Deschloroetizolam Etizolam Flubrotizolam Fluclotizolam Fluetizolam Israpafant* JQ1* Metizolam
Thienobenzodiazepines*	Olanzapine Telenzepine
Pyridodiazepines	Lopirazepam
Pyridotriazolodiazepines	Zapizolam
Pyrazolodiazepines	Razobazam* Ripazepam Zolazepam Zomebazam Zometapine*
Pyrrolodiazepines	Premazepam
Tetrahydroisoquinobenzodiazepines	Clazolam
Pyrrolobenzodiazepines*	Anthramycin
Benzodiazepine prodrugs	Alprazolam triazolobenzophenone Avizafone Rilmazafone
* atypical activity profile (not GABA_A receptor ligands)

This sedative-related article is a stub. You can help Misplaced Pages by expanding it.

Categories:

Revision as of 16:20, 20 November 2011

See also

References